FindMyKOL
Clinical trialNCT00802802CompletedPhase 1Interventional

Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment67HIV InfectionsTuberculosis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years of age. This study is being conducted to look at the safety of EFV, blood levels of EFV, genetic factors that may affect blood levels of EFV, and how easy it is for infants and young children to take and tolerate EFV. This information will help recommend the best doses of EFV for children younger than 3 years of age.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

India
  • Byramjee Jeejeebhoy Medical College (bjmc) Crs

    Pune, Maharashtra, India

South Africa
  • Shandukani Research Crs

    Johannesburg, Gauteng, South Africa

  • Soweto Impaact Crs

    Johannesburg, Gauteng, South Africa

  • Durban Paediatric Hiv Crs

    Durban, KwaZulu-Natal, South Africa

  • Family Clinical Research Unit (fam-Cru) Crs

    Tygerberg Hills, Western Cape, South Africa

Uganda
  • Mu-Jhu Research Collaboration (mujhu Care Ltd) Crs

    Kampala, Uganda

Zimbabwe
  • Harare Family Care Crs

    Harare, Zimbabwe

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Efavirenz →Rifampin-containing anti-TB therapy
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
10 Feb 2010
Primary completion
18 Mar 2016
Completion
16 Feb 2018
Last update posted
1 Nov 2021
Registered enrollment
67
Registry id
NCT00802802
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.